Patient Assistance Screener

Do You Qualify for Free GLP-1 Medication?

May 2026  |  BetterNewLives.com

Lilly Cares Foundation and the Novo Nordisk Patient Assistance Program provide free Mounjaro, Zepbound, Ozempic, and Wegovy to qualifying patients — including Medicare and Medicaid beneficiaries. Many people who qualify have never heard of these programs. Answer 4 quick questions to see if you may be eligible.

Question 1 of 4
What is your current insurance situation?
⚠️ Important: This screener provides general eligibility guidance only — it is not a formal determination. Actual eligibility is determined by each program based on your complete application. Always apply directly through the manufacturer's program.

About These Programs

Patient assistance programs (PAPs) are manufacturer-funded programs that provide free medication to patients who cannot afford their medications. Unlike savings cards — which are prohibited for Medicare/Medicaid beneficiaries — PAPs are structured to comply with federal law and are legal for Medicare and Medicaid patients.

Lilly Cares Foundation provides free Mounjaro and Zepbound. Income threshold is generally 400% of the federal poverty level (~$60,240 for a single person in 2026). Applications require physician involvement and take 2–6 weeks to process.

Novo Nordisk Patient Assistance Program provides free Ozempic and Wegovy under similar eligibility criteria. Income thresholds and application requirements are comparable to Lilly Cares.

Related Resources